hotspot -WSS

hotspot

author：fashion 2025-09-29 20:53:21 - browse：127

Adam's take main illustration — Molly Ferguson/STAT

Cytokinetics was founded 26 years ago but has not yet developed a drug successfully to approval. That makes Tuesday’s Food and Drug Administration decision on its treatment for heart failure a big deal — except nearly everyone, even investors who own Cytokinetics — hopes the agency rules against it.

Hoping the FDA rejects the Cytokinetics drug, called omecamtiv mecarbil, is a relatively uncommon, up-is-down, down-is-up situation, but it makes sense in this case because the business and science of the drug are not aligned.

Consider: Cytokinetics shares rose in December when an outside group of experts convened by the FDA to examine omecamtiv’s benefits and risks recommended against the medicine’s approval. On Tuesday, the FDA is most likely to heed that advice and turn down the company’s marketing application.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Trump’s hydroxychloroquine hype: a risk to my treatment and to him

WSS

Skip the lead apron during X

Leukemia patients are helped by Syndax's new type of therapy

Lupron, used to halt puberty in children, may cause lasting health problems

FDA needs staff influx to meet gene therapy needs, Marks says

Chemotherapy shortages won’t get better under Biden’s latest plan

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

leisure time

hotspot

hotspot

Medical records are filled with copy

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

Duchenne breakthrough therapy leaves behind pioneering families

Leukemia patients are helped by Syndax's new type of therapy

Supreme Court strikes down use of affirmative action

Use doctors trained outside the U.S. to ease the physician shortage

Continuity nursing helped my family in our darkest PICU moments

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

Continuity nursing helped my family in our darkest PICU moments

Undocumented workers face uncertainty as immigration law takes effect in Florida

focus

Beware reading your test results before your doctor does

Security flaws in third

Lupron, used to halt puberty in children, may cause lasting health problems

Americans' trust in science, scientist continues decline: Report

FDA needs staff influx to meet gene therapy needs, Marks says

Lupron, used to halt puberty in children, may cause lasting health problems

entertainment

explore

focus

knowledge